COAG - Company ID 0002114044
The table below shows Hemab Therapeutics Holdings, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 |
|---|---|---|
| Cash & equivalents | $237.37M | $49.86M |
| Short-term investments | $220.09M | $113.67M |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | $464.00M | $169.43M |
| Property, plant & equipment | $596.00K | $648.00K |
| Goodwill | - | - |
| Total assets | $467.78M | $175.26M |
| Accounts payable | $6.23M | $5.68M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $12.94M |
| $13.19M |
| Long-term debt | - | - |
| Total liabilities | $13.51M | $13.71M |
| Retained earnings | -$228.69M | -$204.54M |
| Total equity | $454.27M | -$198.62M |